Reuben A Gittelman R, Gao J, Zhang J, Yusko E, Wu CJ, Emerson R, Chen R, Zhang J, Tipton C, Vence L, Cascone T, Vignali M, Fujimoto J, Rodriguez-Canales J, e P, Forget MA, Federico L, Haymaker C, Behren C, Benzeno S, Bernatchez C, Sepesi B, Gibbons D, Wargo J, Swisher SG , Heymach J, Robins H, Lee JJ, Sharma P, Allison J, Futreal PA, Wistuba I, Zhang J
By now, it should not come as a surprise that GLP-1 agonists like semaglutide and tirzepetide could do this
Summary Microdosing is typically treated as a tolerability-first, clinician-guided approach, involving starts below the usual 2.5 mg step, extending escalation windows from 4 to 8 weeks or more, or pausing at intermediate maintenance doses, such as 5 mg or 7.5 mg, to prioritize steady adherence and symptom control
Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans